E-pharmacies' business surges 25-65% amid second COVID-19 wave
E-pharmacies in India have seen a 25-65 percent jump in their sales, mostly of common drugs, health supplements, medical devices and personal protective equipment (PPE).
A soaring number of infections during the second coronavirus wave in the country, coupled with local lockdowns, have made people turn to online health resources instead of usual visits to offline pharmacies and diagnostic centres, The Economic Times has reported.
Follow our LIVE Updates on the coronavirus pandemic here
1mg said sales of Doxzee and Fabiflu, both used in the treatment of COVID-19, have jumped 40-50 times in April compared to March. The demand for COVID-19 related products increased five times in April from March, it said. Sales would be much higher if product supplies were available.
Prashant Tandon, co-founder and CEO of 1mg, told the newspaper that consumers are “apprehensive about exposure” while venturing outside for medicines and lab results and prefer online options. “…need at present is unbounded,” he said, adding the company was “actively investing” to cater to demand.
View more A vaccine works by mimicking a natural infection. A vaccine not …
More on: www.moneycontrol.com